AU Patent

AU2013302805B2 — Intrauterine contraceptive device

Assigned to Contramed LLC · Expires 2017-10-12 · 9y expired

What this patent protects

A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of t…

USPTO Abstract

A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus and/or device embedment within the uterus.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013302805B2
Jurisdiction
AU
Classification
—
Expires
2017-10-12
Drug substance claim
No
Drug product claim
No
Assignee
Contramed LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.